Saya Biologics
2026-09-03saya.bio
Overview
What they do
Saya Biologics is a pioneering biopharmaceutical company in Latin America focused on expanding patient access to affordable biological medicines. The company builds a portfolio of innovative and biosimilar drugs and works to register, commercialize, and distribute them across the LATAM region. Its model emphasizes strategic international partnerships, agile execution, and a deep understanding of regional healthcare needs to deliver high-quality therapies to patients who need them most.
saya.bio
What they look for
The firm operates as a fund-of-funds and direct investor in private biotech and medical device companies. It scouts promising science from universities, tech transfer offices, and founders, assessing scientific, clinical, IP, and commercial feasibility.
saya.bio
Stage
Seed, Series A, Series B+
saya.bio
Sectors
Healthcare
saya.bio
Based
California City, US
saya.bio
Sources
Portfolio, cheque size and the rest
The 6 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.